BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26775082)

  • 1. Partner status and survival after cancer: A competing risks analysis.
    Dasgupta P; Turrell G; Aitken JF; Baade PD
    Cancer Epidemiol; 2016 Apr; 41():16-23. PubMed ID: 26775082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing mortality risks among women aged 50-79 years when diagnosed with invasive breast cancer, Queensland, 1997-2012.
    Dasgupta P; Aitken JF; Pyke C; Baade PD
    Breast; 2018 Oct; 41():113-119. PubMed ID: 30029053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
    He VY; Condon JR; Baade PD; Zhang X; Zhao Y
    Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. After accounting for competing causes of death and more advanced stage, do Aboriginal and Torres Strait Islander peoples with cancer still have worse survival? A population-based cohort study in New South Wales.
    Tervonen HE; Walton R; You H; Baker D; Roder D; Currow D; Aranda S
    BMC Cancer; 2017 Jun; 17(1):398. PubMed ID: 28577351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating competing risk theory into evaluations of changes in cancer survival: making the most of cause of death and routinely linked sociodemographic data.
    Wright CM; Nowak AK; Halkett G; Moorin RE
    BMC Public Health; 2020 Jun; 20(1):1002. PubMed ID: 32586298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks.
    Thomas AA; Pearce A; Sharp L; Gardiner RA; Chambers S; Aitken J; Molcho M; Baade P
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e31-e40. PubMed ID: 27558311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of competing mortality risks among colorectal cancer survivors in Queensland, 1996-2009.
    Dasgupta P; Youlden DR; Baade PD
    Cancer Causes Control; 2013 May; 24(5):897-909. PubMed ID: 23408244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying the changes in survival inequality for Indigenous people diagnosed with cancer in Queensland, Australia.
    Baade PD; Dasgupta P; Dickman PW; Cramb S; Williamson JD; Condon JR; Garvey G
    Cancer Epidemiol; 2016 Aug; 43():1-8. PubMed ID: 27186865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
    Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
    Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.
    Baade PD; Youlden DR; Andersson TM; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
    BMJ Open; 2015 Apr; 5(4):e006740. PubMed ID: 25869684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-cancer mortality among people diagnosed with cancer (Australia).
    Baade PD; Fritschi L; Eakin EG
    Cancer Causes Control; 2006 Apr; 17(3):287-97. PubMed ID: 16489536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in net and crude probability of death from cancer and other causes in the Australian population, 1984-2013.
    Dasgupta P; Cramb S; Kou K; Yu XQ; Baade PD
    Cancer Epidemiol; 2019 Oct; 62():101568. PubMed ID: 31330423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
    Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
    Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial inequalities in colorectal and breast cancer survival: premature deaths and associated factors.
    Cramb SM; Mengersen KL; Turrell G; Baade PD
    Health Place; 2012 Nov; 18(6):1412-21. PubMed ID: 22906754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
    Green AC; Baade P; Coory M; Aitken JF; Smithers M
    J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
    Yeole BB; Kumar AV
    Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
    Shen W; Sakamoto N; Yang L
    BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.